paxlovid and semaglutide Wegovy® Weight Loss Prescription Online Pfizer's Paxlovid Covid Pill Granted

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Understanding their differences can help you and your provider determine which option may be best suited for your weight loss goals

A wave of anecdotal reports describing unexpected benefits for patients taking GLP-1 receptor agonists such as weight loss wonder drug Semaglutide is now being followed by a barrage of international headlines confirming significantly reduced cravings for alcohol, smoking and other addictions and compulsive behaviours

Rizo: Clinical trials have revealed a reduction in cognitive impairment in patients with type 2 diabetes treated with GLP-1

Mounjaro, containing tirzepatide, works similarly to semaglutide but targets both GLP-1 and GIP receptors, potentially enhancing its effects on blood sugar and weight loss

Helpful stuff